-
Firefly Luciferase mRNA: Workflow & Optimization
2026-08-31
Build cleaner mRNA delivery experiments with a Cap1-capped, 5-moUTP-modified luciferase transcript designed for strong, sustained reporter expression. Use it to compare transfection systems, evaluate organ-selective lipid nanoparticles, and separate delivery failure from translation or cell-health effects.
-
Sex Differences in Ang II Hypertension in Mice
2026-08-31
This study used conscious-mouse telemetry, gonadectomy, baroreflex testing, and ganglionic blockade to show that chronic angiotensin II produces a substantially larger hypertensive response in males than in females. Its findings connect sex-dependent blood pressure regulation with altered baroreflex control and a stronger sympathetic contribution in male mice, providing a useful framework for mechanistic hypertension research.
-
IR-820 (New Indocyanine Green) Imaging Workflows
2026-08-30
IR-820 supports quantitative near-infrared fluorescence imaging across vascular mapping, tumor localization, and diseased tissue measurement. This workflow-focused guide separates validated study insights from practical pilot conditions so researchers can optimize signal, controls, and longitudinal readouts without overinterpreting therapeutic nanomedicine data.
-
Cy3 RNA Labeling Kit: Practical Workflow Guide
2026-08-29
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based detection. It is intended for research applications such as in situ hybridization and Northern blot hybridization, not for diagnostic, clinical, or therapeutic use.
-
RSL3 Workflow for GPX4-Driven Ferroptosis
2026-08-28
RSL3 provides a direct way to test whether GPX4 dependence drives lipid-peroxidation-mediated cell death, with practical value in RAS-driven cancer models and glioblastoma studies. This workflow combines dose-response design, ferroptosis rescue controls, lipid ROS measurements, and ALOXE3-aware interpretation.
-
Cytochalasin B: Applied Actin Assay Workflows
2026-08-28
Cytochalasin B, also known as NSC 107658, provides reversible control over actin-dependent morphology, migration, uptake, and division. This workflow-focused guide shows how to convert that pharmacology into reproducible cell assays while using the reference study’s complementary cytotoxicity and genotoxicity framework to avoid overinterpreting a single endpoint.
-
Partial BACE Inhibition and Synaptic Safety
2026-08-27
Satir et al. tested whether moderate β-secretase inhibition can lower amyloid-β secretion without impairing neuronal function. Using optical electrophysiology in primary rat cortical cultures, the study found that amyloid beta reduction of less than 50% was not accompanied by measurable synaptic transmission deficits, whereas stronger inhibition reduced both readouts.
-
Sulfo-Cy3 NHS Ester for Vascular Assays
2026-08-27
Sulfo-Cy3 NHS Ester combines aqueous compatibility with amine-reactive labeling for tracking proteins, HDL-associated cargo, and endothelial uptake. This workflow-focused guide shows how to adapt a hydrophilic fluorescent dye to AIBP–LRP2–CXCR4 vascular assays while controlling labeling density, background, and probe function.
-
Cy3 Goat Anti-Human IgG (H+L): Assay Design
2026-08-26
The Cy3 Goat Anti-Human IgG (H+L) Antibody supports epitope-aware fluorescence workflows for human IgG detection. This guide connects secondary-antibody selection with orthopoxvirus antibody research, clarifying assay scope, controls, optical setup, and translational limitations.
-
Epalrestat: From Polyol Control to Nrf2 Biology
2026-08-26
Epalrestat is an aldose reductase inhibitor with applications spanning polyol pathway and neuroprotection research. This article presents an evidence-based framework for separating direct enzyme inhibition from KEAP1/Nrf2-dependent effects when designing diabetic neuropathy and Parkinson’s disease model assays.
-
Simvastatin (Zocor): Cholesterol–Ferroptosis
2026-08-25
Simvastatin (Zocor) is examined here as a mechanistic probe connecting HMG-CoA reductase inhibition with cholesterol trafficking and GPX4-linked ferroptosis. This article translates recent glioblastoma findings into practical assay decisions while distinguishing established evidence from testable cancer hypotheses.
-
WNT5a/GSK3/β-Catenin Controls FAP Adipogenesis
2026-08-25
The reference study identifies the WNT5a/GSK3/β-catenin axis as a central regulator of adipogenic drift in skeletal muscle fibro/adipogenic progenitors. By integrating pharmacological perturbation, mass cytometry, transcriptomics, network modeling, and mouse injury models, it connects impaired WNT5a signaling with muscle fat accumulation and suggests mechanisms for preserving FAP-supported regeneration.
-
AIBP–LRP2–HDL Axis in Collateral Vessel Growth
2026-08-24
Zhu et al. identify an AIBP–LRP2–HDL–miR-223 pathway that limits the expansion of CXCR4-positive, stemlike capillary endothelial cells during collateral circulation. The study supports a two-phase model in which these cells first expand and later acquire arterial characteristics, offering a mechanistic framework for therapeutic revascularization research.
-
Cy3 NHS ester (non-sulfonated) Protocol Guide
2026-08-24
Cy3 NHS ester (non-sulfonated) provides an orange-emitting NHS ester for fluorescent labeling of primary amino groups in soluble proteins, peptides, oligonucleotides, and DNA. It is suited to workflows that can tolerate a DMSO or DMF co-solvent, but its water insolubility makes sulfonated Cy3 NHS ester alternatives preferable for especially solvent-sensitive biomolecules.
-
Protease Inhibitor Cocktail: Preserve Metabolic Signals
2026-08-23
A Protease Inhibitor Cocktail can preserve dynamic metabolic signals during tissue and cell extraction. This guide connects ANGPTL4–LPL biology with EDTA-free assay design, validation, and practical workflow decisions.